Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs Curis, Inc. (CRIS)

Avenue Therapeutics, Inc. and Curis, Inc. are both Biotechnology companies. Curis, Inc. is the larger, with a market value of $1.1M against $680.0K — 1.6× the size. Across the 9 metrics below, Curis, Inc. leads on 5 and Avenue Therapeutics, Inc. on 4.

Valuation

Metric ATXI CRIS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.09 9.71
P/B 2.49 0.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.05 0.41 0.64
EV/Sales n/m (0.37) 9.21
Earnings yield (197.67%) (3,468.29%) (33.15%)
Free cash flow yield (97.68%) (3,540.29%) (25.50%)

Profitability

Metric ATXI CRIS Biotechnology median
Gross margin — 99.52% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) 455.35% (56.36%)
Return on assets (90.50%) (87.76%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI CRIS Biotechnology median
Revenue growth (TTM) — (13.43%) 6.02%
EPS growth (last fiscal year) 89.70% 91.57% 30.26%
Revenue growth, 5-year CAGR — (2.71%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI CRIS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 0.49 4.72
Net debt to EBITDA 0.93 0.91 0.96

Dividend

Metric ATXI CRIS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATXI CRIS Biotechnology median
Market cap 680.00k 1.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack